Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance

Background Circulating microRNAs (miRNAs) from blood are increasingly recognized as biomarker candidates for human diseases. Clinical routine settings frequently include blood sampling in tubes with EDTA as anticoagulant without considering the influence of phlebotomy on the overall miRNA expression pattern. We collected blood samples from six healthy individuals each in an EDTA blood collection tube. Subsequently, the blood was transferred into PAXgeneTM tubes at three different time points, i.e. directly (0 min), 10 min, and 2 h after phlebotomy. As control blood was also directly collected in PAXgeneTM blood RNA tubes that contain a reagent to directly lyse blood cells and stabilize their content. For all six blood donors at the four conditions (24 samples) we analyzed the abundance of 1,205 miRNAs by human Agilent miRNA V16 microarrays. Results While we found generally a homogenous pattern of the miRNA abundance in all 24 samples, the duration of the EDTA treatment appears to influence the miRNA abundance of specific miRNAs. The most significant changes are observed after longer EDTA exposition. Overall, the impact of the different blood sample conditions on the miRNA pattern was substantially lower than intra-individual variations. While samples belonging to one of the six individuals mostly cluster together, there was no comparable clustering for any of the four tested blood sampling conditions. The most affected miRNA was miR-769-3p that was not detected in any of the six PAXgene blood samples, but in all EDTA 2h samples. Accordingly, hsa-miR-769-3p was also the only miRNA that showed a significantly different abundance between the 4 blood sample conditions by an ANOVA analysis (Benjamini-Hochberg adjusted p-value of 0.003). Validation by qRT-PCR confirmed this finding. Conclusion The pattern of blood-borne miRNA abundance is rather homogenous between the four tested blood sample conditions of six blood donors. There was a clustering between the miRNA profiles that belong to a specific blood donor, but not between any of the four tested blood sampling conditions. The results show a limited overall impact of the blood sampling conditions on the miRNA pattern. Notwithstanding, the abundance of single miRNAs can be significantly altered by different blood sampling conditions.

[1]  Hyeon-Ok Jin,et al.  Comparison of three different kits for extraction of high-quality RNA from frozen blood , 2014, SpringerPlus.

[2]  J. Yasuda,et al.  Inference of Gene Regulation via miRNAs During ES Cell Differentiation Using MiRaGE Method , 2011, International journal of molecular sciences.

[3]  Uwe Oelmueller,et al.  Stabilization of mRNA expression in whole blood samples. , 2002, Clinical chemistry.

[4]  K. Raddassi,et al.  Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation , 2008, BMC Genomics.

[5]  K. Brune,et al.  Stabilization of gene expression profiles in blood after phlebotomy. , 2002, Clinical chemistry.

[6]  S. Burchill,et al.  Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling. , 2012, Analytical biochemistry.

[7]  C. Shaw,et al.  Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. , 2010, Blood.

[8]  B. Millar,et al.  Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. , 1992, Journal of immunological methods.

[9]  Y. Y. Li,et al.  Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation , 2010, Neuroscience Letters.

[10]  Keith W. Jones,et al.  Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis , 2012, PloS one.

[11]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[12]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[13]  P. Gunaratne,et al.  The Repertoire and Features of Human Platelet microRNAs , 2012, PloS one.

[14]  D. Ruff,et al.  Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. , 2002, Clinical and laboratory haematology.

[15]  L. Alberio,et al.  A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon , 2014, BMC Clinical Pathology.

[16]  R. Freeman,et al.  In-vitro production of TNF-α in blood samples , 1990, The Lancet.

[17]  Christina Backes,et al.  Toward the blood-borne miRNome of human diseases , 2011, Nature Methods.

[18]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[19]  Evelyn Wenkel,et al.  Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection , 2012, PloS one.

[20]  C. Romualdi,et al.  Integration Analysis of MicroRNA and mRNA Expression Profiles in Human Peripheral Blood Lymphocytes Cultured in Modeled Microgravity , 2014, BioMed research international.

[21]  M. Hellmich,et al.  Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.

[22]  C. Lathia,et al.  Recovery of microarray-quality RNA from frozen EDTA blood samples. , 2009, Journal of pharmacological and toxicological methods.